Korean J Med Mycol.  2008 Mar;13(1):31-36.

Chronic Recurrent Cutaneous Mucormycosis due to Rhizopus arrhizus

Affiliations
  • 1Department of Dermatology, Daegu Catholic University School of Medicine, Daegu, Korea. jbjun@cu.ac.kr
  • 2Department of Dermatology, Kyungpook National University School of Medicine, Daegu, Korea.
  • 3Institute of Medical Mycology, Catholic Skin Clinic, Daegu, Korea.

Abstract

Mucormycosis occurs primarily in patients with severe underlying illness, especially leukemia, lymphoma, and uncontrolled diabetes mellitus. Cutaneous mucormycosis is somewhat less frequently associated with systemic illness than other forms of mucormycosis. It develops where a break in the integrity of the skin has occurred as a result of surgery, burn, or other forms of trauma. We report herein a case of primary cutaneous mucormycosis due to Rhizopus arrhizus in a 24-year-old healthy man without systemic illness, who developed recurrent, prograssively extending, weeping and tender swollen ulcerative patches at the artificial trauma site on the right side of his face since 9 years of age. It was successfully treated with amphotericin B ointment combined with oral itraconazole and ketoconazole.

Keyword

Amphotericin B ointment; Primary cutaneous mucormycosis; Rhizopus arrhizus

MeSH Terms

Amphotericin B
Burns
Diabetes Mellitus
Humans
Itraconazole
Ketoconazole
Leukemia
Lymphoma
Mucormycosis
Rhizopus
Skin
Ulcer
Young Adult
Amphotericin B
Itraconazole
Ketoconazole
Full Text Links
  • KJMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr